Introduction
============

Hypertension (HTN) is prevalent worldwide and a major public health problem because of the significant role it plays in the development of cardiovascular and cerebrovascular diseases \[[@b1-ophrp-10-327],[@b2-ophrp-10-327]\]. It is one of the principal modifiable risk factors in both the development of cardiovascular diseases and the resultant morbidity and mortality \[[@b3-ophrp-10-327],[@b4-ophrp-10-327]\]. Globally, about 13% of the total deaths each year is attributable to HTN \[[@b5-ophrp-10-327]\]. In addition, HTN accounts for about 4% of the annual disability-adjusted life-years \[[@b6-ophrp-10-327]\].

The American College of Cardiology and the American Heart Association (2017) defined HTN primarily in 2 stages. Stage 1 is defined as systolic arterial blood pressure \[systolic BP (SBP)\] between 130--139 mmHg and a diastolic arterial BP (DBP) between 80--89 mmHg. Stage 2 is defined as the systolic arterial blood pressure being 140 mmHg or above, and the diastolic arterial BP being 90 mmHg or above \[[@b7-ophrp-10-327]\]. However, in many hypertensive patients, HTN does not manifest its classical form and SBP or DBP may rise independently. In these cases HTN is known as Isolated Systolic Hypertension \[ISH (SBP ≥ 140 mmHg and DBP \< 90 mmHg)\] and Isolated Diastolic Hypertension \[IDH (SBP \< 140 mmHg and DBP ≥ 90 mmHg)\] \[[@b8-ophrp-10-327]--[@b11-ophrp-10-327]\]. Increased stiffness or reduced elasticity of the arteries causes ISH, whereas IDH is induced by a rise in arteriole resistance \[[@b12-ophrp-10-327]\]. ISH has been reported to be more common among older adults \[[@b13-ophrp-10-327]\], and associated with an increased risk of developing cardiac failure in the elderly \[[@b14-ophrp-10-327]\]. In the past, IDH did not get as much consideration as the other forms of HTN \[[@b11-ophrp-10-327],[@b15-ophrp-10-327]\], but its importance should not be overlooked \[[@b16-ophrp-10-327]\]. IDH also increases the risk of developing cardiovascular diseases, though the magnitude is lower than with other HTN subtypes \[[@b10-ophrp-10-327]\]. Combined systolic/diastolic HTN (SDH) is also associated with cardiovascular and cerebrovascular diseases \[[@b17-ophrp-10-327]\].

Lowering the mean DBP was reportedly associated with a reduced risk of developing cerebrovascular, and coronary heart diseases by 35--40% and 20--25%, respectively \[[@b18-ophrp-10-327],[@b19-ophrp-10-327]\]. Additionally, a meta-analysis of 61 longitudinal studies showed that people aged 40--69 years had an absolute proportional difference in BPs that was almost the same as an absolute proportional difference in mortality risk due to cardiovascular diseases, up to a certain level of DBP and SBP \[[@b20-ophrp-10-327]\]. In that study, an absolute proportional difference of 20 mmHg in SBP or 10 mmHg in DBP was reported to be associated with a 2-fold absolute proportional difference in the mortality risk due to myocardial infarction or cerebrovascular attacks, wherein SBP and DBP were at least 115 mmHg and 75 mmHg, respectively \[[@b20-ophrp-10-327]\].

The World Health Organization (WHO) reported the alarming burden non-communicable diseases (NCDs) pose worldwide and regionally. More than two-thirds of deaths globally, and about three-quarters of deaths in low- and middle-income countries are attributable to NCDs \[[@b5-ophrp-10-327]\]. Like other parts of the world, South Asian countries have undergone overwhelming demographic and epidemiological transitions. Consequently, there has been a massive shift in cause-specific mortality. The burden of NCDs, such as metabolic disease, cardiovascular disease, and cancers has increased and South Asian people have been more susceptible to these diseases, compared to other ethnic groups \[[@b21-ophrp-10-327]--[@b23-ophrp-10-327]\]. Nepal, is currently facing an epidemiological transition due to the increasing burden of NCDs, including HTN \[[@b24-ophrp-10-327]\]. Data from the nationally representative Nepal Demographic and Health Survey (NDHS) in 2016, estimated that 1 in 5 adults in Nepal (aged ≥ 18 years) were hypertensive \[[@b25-ophrp-10-327],[@b26-ophrp-10-327]\]. However, Nepal does not have representative data regarding HTN subtypes and their associated factors. The burden of NCDs in Nepal, along with ISH and IDH, warrant regular reporting of nationally representative data on HTN subtypes, so that preventive modalities can be designed. This study aims to determine the prevalence, distribution, and associated factors of ISH, IDH as well as SDH, in Nepal using the NDHS 2016 data.

Materials and Methods
=====================

1. Study design
---------------

A secondary analysis of the nationally representative Nepal Demographic and Health Survey (NDHS) 2016 data was conducted. Under the leadership of the Nepal Ministry of Health, NDHS 2016 was administered by NEW ERA from June 2016 to January 2017 \[[@b25-ophrp-10-327]\].

NDHS 2016 utilized the updated sampling frame of the 2011 Nepal National Population and Housing Census. For data collection, stratified cluster sampling of households was followed. In the rural area, a 2-staged stratified sampling technique was followed. At first, 199 primary sampling units (PSUs) were selected based on the probability proportional to size method. At the second stage, households were systematically selected from each PSU. On the other hand, a 3-staged stratified sampling technique was used in the urban area. At the first stage, PSUs (*n* = 184) were selected by the probability proportional to size method. Then, enumeration areas were randomly selected from each PSU. At the final stage, households were systematically selected from each enumeration area. A total of 11,490 households (5,520 urban households and 5,970 rural households) were included in the final sample. The detailed methodology has been previously published \[[@b25-ophrp-10-327]\].

2. Outcome
----------

Adult Nepalese men and women aged 18 years and above were included in this study. The outcomes of interest of this study were ISH, IDH, and combined systolic/diastolic HTN (SDH). BP was measured using UA-767F/FAC (A&D Medical) BP monitors, and depending on the respondent's arm circumference, small, medium, or large size cuffs were used. For each individual, BP was measured 3 times. After discarding the first measurement, the average of the second and third measurement was reported as the BP of the respondent \[[@b25-ophrp-10-327]\]. In this study, HTN was defined as having an average SBP ≥ 140 mmHg and an average DBP ≥ 90 mmHg. If the individual was taking any antihypertensive medication at the time of the survey irrespective of BP level, he/she was classified as hypertensive \[[@b27-ophrp-10-327]\]. SDH was defined as an average SBP ≥ 140 mmHg and an average DBP ≥ 90 mm Hg \[[@b8-ophrp-10-327]\]. ISH was defined as an average SBP ≥ 140 mmHg and an average DBP \< 90 mmHg, and IDH was defined as an average SBP \< 140 mmHg and an average DBP ≥ 90 mm Hg \[[@b8-ophrp-10-327]\].

3. Explanatory variables
------------------------

Based on literature review, potential explanatory variables that were considered included age (18--29 years, 30--49 years, 50--69 years, ≥ 70 years), gender (male, female), marital status (never married, had been married), highest educational attainment (no formal education, primary education, secondary education and above), household wealth index (poorest, poor, middle, rich, richest), place of residence (urban, rural), province of residence (Province 1, Province 2, Province 3, Province 4, Province 5, Province 6, Province 7), ecological region of residence (the Terai, hills, mountains), and body mass index \[BMI, underweight (\< 18.5 kg/m^2^), normal weight (18.5--23 kg/m^2^), overweight/obese (≥ 23 kg/m^2^)\]. BMI was defined using the Asian cut-off value \[[@b28-ophrp-10-327]\]. Household wealth index was calculated using principal component analysis of selected assets, i.e., construction materials used for the roof and floor of the household, types of water source and sanitation facilities, access to electricity, and other belongings (television, bicycle, etc.) \[[@b25-ophrp-10-327],[@b29-ophrp-10-327],[@b30-ophrp-10-327]\].

4. Statistical analysis
-----------------------

Descriptive analyses of the selected variables (both of the outcome variable and the covariates) were conducted. As all the variables were categorical, they were described using frequencies and percentages. Pearson's Chi-square test was used to observe any differences among the covariates across the BP status of the respondents. The sample weight of the NDHS 2016 was adjusted during the analyses.

Multilevel logistic regression analyses were conducted to find the association between the independent variables (SDH, ISH, and IDH) and the covariates. Multilevel logistic regression was conducted considering the complex hierarchical structure of the DHS dataset \[[@b31-ophrp-10-327]--[@b33-ophrp-10-327]\]. At first, bivariate analysis was performed to determine the crude odds ratio (COR) with a 95% confidence interval (CI) with each of the covariates. Those variables, which yielded a pre-determined *p* \< 0.2 in the bivariate analyses (which was sufficient to adjust for the additional residual confounding effect), were put into the final multivariate logistic regression model to yield the adjusted odds ratio (AOR) \[[@b34-ophrp-10-327]\]. In the final logistic regression model, those covariates which yielded a *p* \< 0.05 were considered statistically significant. Any possible existence of multicolinearity among the covariates was checked using the variance inflation factor. A variance inflation factor value greater than 5 was considered as an indication of multicolinearity \[[@b35-ophrp-10-327]\]. However, no statistically significant multicolinearity was observed. Stata 14.0 was used for data analyses. The guidelines outlined in the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement were followed in conducting this study and writing the manuscript ([Appendix A](#t4-ophrp-10-327){ref-type="table"}) \[[@b36-ophrp-10-327]\].

5. Ethical consideration
------------------------

NDHS, 2016 received ethical approval from the ethical review board of the Nepal Research Council (approval number: 329/2015) and ICF International (approval no.: ICF IRB FWA00002349). Before data collection, informed consent was given by the respondents.

Results
=======

1. Characteristics of the respondents
-------------------------------------

A weighted sample of 13,393 Nepalese males and females aged ≥ 18 years of age, were included in the final analyses. Nearly two-thirds (61.2%) of the respondents were from urban areas. About two-fifths (41.6%) of the study participants did not have any formal education. The respondents were almost equally distributed across the 5 wealth quintiles. Almost half of the people (49.6%) were from the Terai region, 44% belonged to the hilly areas, and the rest (6.4%) were from the mountains. More than a third (36%) of the participants were overweight or obese ([Table 1](#t1-ophrp-10-327){ref-type="table"}).

The weighted prevalence of HTN was 21.1%. The group of young adults (18--29 years of age) had the least prevalence of HTN (6.1%) compared to the other age groups. Around one-fifth (21.7%) of the middle-aged (30--49 years), and about two-thirds (34.5%) of the older adults (50--69 years) had HTN. The elderly group (≥ 70 years of age) had the highest proportion (43.5%) of HTN. The prevalence of HTN was higher among males than females (male versus female: 25.4% versus 18%, *p* \< 0.001). The highest prevalence of HTN was observed among those with no formal education (24.5%, *p* \< 0.001), from the richest wealth quintile (28.3%, *p* \< 0.001). Around a quarter of the Nepalese population in Province 3, Province 4, and Province 5, had HTN (24.9%, 28.8%, and 23.3%, respectively). The prevalence of HTN was higher in those 3 provinces than in other regions (*p* \< 0.001). Considering the ecology of the habitat, the population in the hilly areas had the highest prevalence of HTN (24.2%, *p* \< 0.001), compared to populations from other ecological regions. Higher prevalence was also observed among overweight/obese individuals (30.8%, *p* \< 0.001) than other BMI categories ([Table 1](#t1-ophrp-10-327){ref-type="table"}).

2. Age- and gender-specific prevalence of ISH, IDH and SDH
----------------------------------------------------------

The age- and gender-specific prevalence of ISH, IDH, and SDH are presented in [Table 2](#t2-ophrp-10-327){ref-type="table"}. Overall, 18.9% of the respondents had undiagnosed and untreated HTN. The prevalence of undiagnosed and untreated SDH, IDH, and ISH was 8.1% (95% CI: 7.4%--8.9%), 7.5% (95% CI: 6.9%--8.1%), and 3.3% (95% CI: 3.0%--3.7%), respectively. The prevalence was higher among males in all 3 sub-categories. In the case of undiagnosed and untreated SDH and ISH, the prevalence in both genders were higher among the older age-groups. However, in the case of undiagnosed and untreated IDH, the highest prevalence was observed in males and females aged 30--49 years.

3. Factors associated with undiagnosed and untreated HTN
--------------------------------------------------------

The factors associated with undiagnosed and untreated HTN subtypes are described in [Table 3](#t3-ophrp-10-327){ref-type="table"}. In the multivariate analyses, several demographic variables (e.g. age, gender), socioeconomic variables (e.g. education, province), and BMI were observed to have a statistically significant association with participants having ISH, IDH, or SDH, when adjusted for the potential confounders.

The odds of having undiagnosed and untreated SDH and ISH, were higher among the older age-groups, whereas for IDH it was younger ages. Gender was also statistically significantly associated with undiagnosed and untreated SDH and IDH. Being female was associated with a significantly reduced odds of having undiagnosed and untreated SDH (AOR 0.6; 95% CI: 0.5--0.7, *p* \< 0.001) and IDH (AOR 0.6; 95% CI: 0.5--0.7, *p* \< 0.001). Household wealth index was statistically significantly associated with undiagnosed and untreated SDH and ISH. A Nepalese adult from a poorer quintile household, had higher odds (AOR 1.3; 95% CI: 1.0--1.6, *p* \< 0.05) of having undiagnosed SDH, compared with a person from the poorest quintile household. In contrast, being a person from the richest quintile household increased the odds of having undiagnosed ISH (AOR 1.8; 95% CI: 1.2--2.8, *p* \< 0.01) compared with a person from the poorest quintile household. Residents of Province 4 had higher odds of having undiagnosed and untreated SDH (AOR 1.5; 95% CI: 1.0--2.2, *p* \< 0.05) and IDH (AOR 1.5; 95% CI: 1.1--2.1, *p* \< 0.05) compared to residents from Province 1. In addition, a resident of Province 5 had higher odds (AOR 1.6; 95% CI: 1.2--2.2, *p* \< 0.01) of having undiagnosed and untreated IDH than a resident of Province 1. Being overweight/obese increased the likelihood of having undiagnosed and untreated SDH, ISH, and IDH. An overweight/obese individual was more likely to have undiagnosed and untreated SDH (AOR 2.2; 95% CI: 1.9--2.6, *p* \< 0.001) and IDH (AOR 2.2; 95% CI: 1.9--2.6, *p* \< 0.001) compared to an individual of normal body weight. In contrast, being underweight reduced the odds of having undiagnosed and untreated SDH (AOR 0.6; 95% CI: 0.5--0.8, *p* \< 0.001) and IDH (AOR 0.6; 95% CI: 0.5--0.8, *p* \< 0.001) statistically significantly compared to an individual with a normal body weight.

Discussion
==========

To the best of our knowledge, this was the first study from Nepal to identify the prevalence, and factors associated with undiagnosed and untreated ISH, IDH, and SDH among the adult population in Nepal. Around one-fifth of the adult Nepalese population was suffering from undiagnosed and untreated HTN. The prevalence of IDH and SDH were high followed by ISH. In both males and females, the prevalence of SDH and ISH increased with age. On the other hand, IDH was more prevalent in the 30--49 years age group. Age, gender, marital status, household wealth status, province of residence, and BMI was associated with HTN subtypes.

The findings of this study were consistent with the studies conducted on HTN subtypes in other developing nations \[[@b8-ophrp-10-327],[@b11-ophrp-10-327],[@b37-ophrp-10-327],[@b38-ophrp-10-327]\]. The prevalence of ISH was similar to the reported prevalence from neighboring Northern India (male: 5.1%; female: 3.6%) and Bangladesh (male: 3.0%; female: 4.7%) \[[@b8-ophrp-10-327],[@b38-ophrp-10-327]\]. On the other hand, it was lower than the reported prevalence of ISH in China (7.6%) \[[@b37-ophrp-10-327]\]. The reported IDH prevalence (7.5%) in this current study was higher than the reported prevalence from Bangladesh (5.2%) and India (4.5%) \[[@b8-ophrp-10-327],[@b11-ophrp-10-327]\]. The SDH prevalence (8.1%) was also higher than the reported prevalence from Bangladesh (5.2%) \[[@b8-ophrp-10-327]\]. Differences in measurement methods may impair direct comparison between studies. The higher prevalence estimates in China may be attributed to the increased westernization compared with its neighboring counterparts \[[@b37-ophrp-10-327]\]. When comparing between studies it should be noted whether a study is regional or national. There is a paucity of nationwide data in terms of prevalence of undiagnosed IDH in India. Kanpur, being an industrial city has better health-care and diagnostic systems, hence a lower estimate of the prevalence of undiagnosed IDH is observed \[[@b11-ophrp-10-327]\]. The Bangladeshi study included an adult population aged ≥ 35 years, whereas the current study included individuals aged ≥ 18 years \[[@b8-ophrp-10-327]\]. This could explain the higher prevalence of IDH in Nepal than that of Bangladesh and India.

The prevalence of ISH and IDH increased and decreased respectively, with increasing age in this current study. Increasing age was observed to be associated with undiagnosed and untreated ISH and SDH. Age is a non-modifiable risk factor of HTN subtypes \[[@b39-ophrp-10-327]\]. With increasing age, and arterial stiffness increases, resulting in a higher prevalence of elevated BP \[[@b40-ophrp-10-327]\]. Previous evidence showed that between the age of 30--84 years, the prevalence of SBP increases \[[@b41-ophrp-10-327]\]. The prevalence of IDH was the highest among the 30--49 years age group. The odds of IDH decreased with increasing age. This is because diastolic DBP increases up to the age of 50 years due to increased peripheral vascular resistance in small blood vessels, and then gradually decreases \[[@b40-ophrp-10-327],[@b41-ophrp-10-327]\].

Being male was positively associated with SDH and IDH. Aryal et al \[[@b42-ophrp-10-327]\] reported a higher prevalence of smoking, physical inactivity, high blood sugar, and total blood cholesterol among Nepalese males, compared to their female counterparts \[[@b42-ophrp-10-327]\]. Smoking, physical inactivity, high blood sugar, and total blood cholesterol were major risk factors, which increase arterial stiffness and contributed to HTN \[[@b43-ophrp-10-327]--[@b46-ophrp-10-327]\]. The findings in this current study do not align with a similar study performed in neighboring Bangladesh, where being female was reported to be a major associated factor for HTN subtypes \[[@b8-ophrp-10-327]\].

Like the previous studies on HTN performed in Nepal, this current study did not show any consistent relationship patterns between wealth index and HTN subtypes \[[@b47-ophrp-10-327],[@b48-ophrp-10-327]\]. In this study, only the richest wealth index showed a positive association with SDH. People of the richest households tended to have a higher calorific intake, which was compounded with the increased likelihood of leading a sedentary lifestyle, and developing SDH \[[@b49-ophrp-10-327]\].

Residence in Province 4 (later officially renamed Gandaki Pradesh) was positively associated with ISH and IDH. In addition, residence in Province 5 also showed a positive association with IDH. This provincial difference in the associated factors of HTN has been observed in Nepal \[[@b26-ophrp-10-327],[@b50-ophrp-10-327]\]. Regional variations due to differences in socioeconomic conditions and dietary habits have been previously observed in other countries. For Nepal in particular, such disparities led to substantial regional differences in health status \[[@b51-ophrp-10-327],[@b52-ophrp-10-327]\]. Although the higher odds of undiagnosed and untreated IDH in Province 4 and 5 could be attributed to such regional differences of societal and population characteristics, this was beyond the scope of analysis in this current study. Further studies are needed to understand why the prevalence of ISH and IDH was higher in these provinces.

This current study observed that being overweight or obese was positively associated with all of the HTN subtypes, an association previously reported \[[@b8-ophrp-10-327],[@b53-ophrp-10-327]\]. The BP of obese individuals increases due to sympathetic activation, structural changes in the kidney, impairment of pressure natriuresis, and impairment of the renin-angiotensin system, which are further coupled with a high level of circulating insulin, corticosteroid, leptin, and neuropeptides \[[@b54-ophrp-10-327]\]. HTN prevention, and control programs in Nepal should focus on overweight and obese individuals for targeted high-risk approaches.

This study has several notable strengths. The findings of the study are generalizable to the Nepalese people, as a nationally representative sample was analyzed. Due to the utilization of standard and validated tools, the possibility of measurement error was less than other equivalent studies performed in Nepal. The limitations of this study include the causal relationship between the independent and outcome variables which could not be established due to the cross-sectional nature of the study. BP was measured in a single visit, although the standard guidelines recommended longitudinal measurement \[[@b27-ophrp-10-327],[@b52-ophrp-10-327]\]. The relationship between several HTN subtypes with lifestyle factors (dietary habits and physical activities), and smoking could not be evaluated as the NDHS 2016 did not collect data on those variables.

Conclusion
==========

This study observed a high prevalence of undiagnosed and untreated HTN subtypes in the adult Nepalese population. Given the public health importance of these conditions, necessary steps (including awareness against the known risk factors, promotion of physical activity and healthy diet) should be taken by public health promotion programs in Nepal. People who are older, male, overweight or obese, who have a higher socioeconomic condition and are residents of Province 4 (Gandaki Pradesh) or Province 5, had a higher likelihood of suffering HTN and should be enrolled in HTN prevention and control programs.

The authors are thankful to the DHS program for providing permission to use their dataset.
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###### 

Demographic characteristics of the respondents according to blood pressure status (*n* = 13,393).

  Characteristics           Overall   Hypertensive blood pressure status   *p*                           
  ------------------------- --------- ------------------------------------ ------- ------ ------- ------ ----------
  Age (y)                                                                                                \< 0.001
   18--29                   4,337     32.4                                 4,071   93.9   266     6.1    
   30--49                   5,002     37.4                                 3,918   78.3   1,083   21.7   
   50--69                   3,188     23.8                                 2,087   65.5   1,101   34.5   
   ≥ 70                     866       6.5                                  489     56.5   377     43.5   
                                                                                                         
  Gender                                                                                                 \< 0.001
   Male                     5,620     42.0                                 4,191   74.6   1429    25.4   
   Female                   7,773     58.0                                 6,375   82.0   1398    18.0   
                                                                                                         
  Marital status                                                                                         \< 0.001
   Never married            1,529     11.4                                 1,426   93.3   103     6.7    
   Have been married        11,864    88.6                                 9,140   77.0   2724    23.0   
                                                                                                         
  Education                                                                                              \< 0.001
   No formal education      5,572     41.6                                 4,207   75.5   1365    24.5   
   Primary                  2,172     16.2                                 1,698   78.2   474     21.8   
   Secondary                3,699     27.6                                 3,019   81.6   680     18.4   
   Higher                   1,950     14.6                                 1,641   84.2   309     15.8   
                                                                                                         
  Household wealth status                                                                                \< 0.001
   Poorest                  2,396     17.9                                 1,947   81.3   449     18.7   
   Poorer                   2,594     19.4                                 2,046   78.9   549     21.1   
   Middle                   2,666     19.9                                 2,191   82.2   475     17.8   
   Richer                   2,917     21.8                                 2,363   81.0   554     19.0   
   Richest                  2,820     21.1                                 2,019   71.6   801     28.4   
                                                                                                         
  Place of residence                                                                                     0.0147
   Urban                    8,191     61.2                                 6,360   77.6   1,831   22.4   
   Rural                    5,201     38.8                                 4,206   80.9   996     19.1   
                                                                                                         
  Province                                                                                               \< 0.001
   Province 1               2,365     17.7                                 1,889   79.9   475     20.1   
   Province 2               2,748     20.5                                 2,308   84.0   440     16.0   
   Province 3               2,933     21.9                                 2,202   75.1   732     24.9   
   Province 4               1,380     10.3                                 982     71.2   398     28.8   
   Province 5               2,184     16.3                                 1,675   76.7   509     23.3   
   Province 6               674       5.0                                  565     83.9   109     16.1   
   Province 7               1,109     8.3                                  945     85.2   164     14.8   
                                                                                                         
  Ecological region                                                                                      \< 0.001
   Mountains                856       6.4                                  701     81.9   155     18.1   
   Hills                    5,895     44.0                                 4,469   75.8   1426    24.2   
   The Terai                6,642     49.6                                 5,395   81.2   1,246   18.8   
                                                                                                         
  Body mass index                                                                                        \< 0.001
   Normal weight            6,342     47.4                                 5,310   83.7   1,031   16.3   
   Underweight              2,224     16.6                                 1,914   86.0   311     14.0   
   Overweight/obese         4,826     36.0                                 3,342   69.2   1,485   30.8   

= row percentage.

###### 

Age and gender specific prevalence of ISH- IDH- and combined systolic/diastolic hypertension in the adult Nepalese population.

  Age (y)    Total hypertension (*n*)   Diagnosed and treated hypertension (%), 95% CI   Undiagnosed & untreated hypertension                       
  ---------- -------------------------- ------------------------------------------------ -------------------------------------- ------------------- -------------------
             2,827                      2.2 (1.9--2.6)                                   8.1 (7.4--8.9)                         3.3 (3.0--3.7)      7.5 (6.9--8.1)
                                                                                                                                                    
  Male                                                                                                                                              
   Age (y)                                                                                                                                          
   18--29    143                        0.7 (0.4--1.3)                                   1.7 (1.1--2.5)                         5.3 (0.3--1.1)      6.0 (4.7--7.7)
   30--49    557                        1.5 (0.8--2.7)                                   11.7 (10.0--13.7)                      1.0 (0.6--1.7)      13.2 (11.5--15.0)
   50--69    540                        4.2 (3.1--5.6)                                   17.0 (14.7--19.6)                      6.8 (5.1--9.0)      7.3 (6.0--8.9)
   ≥ 70      189                        7.4 (4.8--11.1)                                  13.2 (10.1--17.1)                      18.5 (14.6--23.3)   3.0 (1.7--5.2)
                                                                                                                                                    
  Total      1,429                      2.5 (1.9--3.2)                                   10.4 (9.3--11.6)                       3.9 (3.2--4.6)      8.7 (7.9--9.6)
                                                                                                                                                    
  Female                                                                                                                                            
   Age (y)                                                                                                                                          
   18--29    122                        0.2 (0.0--0.4)                                   0.8 (0.4--1.4)                         0.1 (0.1--0.3)      3.5 (2.7--4.4)
   30--49    527                        1.5 (1.0--2.2)                                   5.5 (4.6--6.5)                         1.0 (0.6--1.6)      9.7 (8.5--11.1)
   50--69    561                        5.0 (4.0--6.4)                                   14.9 (12.9--17.2)                      7.1 (5.9--8.6)      6.8 (5.5--8.3)
   ≥ 70      188                        6.1 (4.0--9.3)                                   16.2 (12.5--20.7)                      19.7 (16.0--24.0)   3.1 (1.8--5.2)
                                                                                                                                                    
  Total      1,398                      2.1 (1.7--2.5)                                   6.4 (5.8--7.2)                         3.0 (2.5--3.5)      6.6 (5.9--7.3)

CI = confidence interval; SDH = systolic diastolic hypertension; ISH = isolated systolic hypertension; IDH = isolated diastolic hypertension.

###### 

Unadjusted and adjusted odds ratios for factors associated with hypertension amongst adults in Nepal.

  Characteristics           Undiagnosed & untreated SDH                             Undiagnosed & untreated ISH   Undiagnosed & untreated IDH                                                                                                                                                                                                                                                                                                                                                                                              
  ------------------------- ------------------------------------------------------- ----------------------------- ------------------------------------------------------- ---------------- -------------------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------------------------- --------------- ------------------------------------------------------ ------------ ------------------------------------------------------ ------------
  Age (y)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   18--29                   Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   30--49                   9.1[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (6.7--12.3)                   7.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (5.1--10.2)      4.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (2.4--8.8)                                                                         4.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (2.2--9.6)      3.1[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (2.6--3.6)   2.4[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (1.9--2.9)
   50--69                   22.3[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (16.5--30.3)                  19.7[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (13.7--28.2)     39.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (21.5--73.0)                                                                       42.9[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (20.9--88.1)    2.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (2.1--3.1)   2.3[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (1.8--3.0)
   ≥ 70                     28.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (20.0--40.6)                  29.4[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (19.4--44.6)     144.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (77.0--271.4)                                                                      166.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (78.7--352.4)   1.41                                                   (1.0--2.2)   1.6[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.0--2.5)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Gender                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
   Male                     Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Female                   0.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.5--0.6)                    0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.5--0.7)       0.7[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (0.6--0.8)                                                                         0.9                                                      (0.7--1.2)      0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (0.6--0.7)   0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (0.5--0.7)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Marital status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
   Never married            Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Have been married        6.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (4.2--9.2)                    1.0                                                     (0.6--1.6)       6.4[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (3.4--12.1)                                                                        0.6                                                      (0.3--1.3)      2.8[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (2.1--3.8)   1.5[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.1--2.1)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Education                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
   No formal education      Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Primary                  0.7[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.6--0.8)                    0.9                                                     (0.8--1.2)       0.4[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (0.3--0.6)                                                                         1.1                                                      (0.7--1.5)      1.3[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.0--1.5)   1.1                                                    (0.9--1.4)
   Secondary                0.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.4--0.5)                    1.0                                                     (0.8--1.2)       0.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (0.1--0.3)                                                                         0.9                                                      (0.6--1.3)      1.1                                                    (0.9--1.3)   1.1                                                    (0.9--1.4)
   Higher                   0.3[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.3--0.4)                    0.9                                                     (0.6--1.2)       0.1[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (0.1--0.2)                                                                         0.8                                                      (0.4--1.4)      0.9                                                    (0.8--1.2)   1.1                                                    (0.9--1.5)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Household wealth status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   Poorest                  Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Poorer                   1.21                                                    (1.0--1.5)                    1.3[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}        (1.0--1.6)       1.0                                                      (0.7--1.3)                                                                         1.1                                                      (0.8--1.5)      1.1                                                    (0.9--1.4)   1.1                                                    (0.8--1.4)
   Middle                   1.0                                                     (0.8--1.3)                    1.1                                                     (0.9--1.5)       0.8                                                      (0.6--1.1)                                                                         0.9                                                      (0.6--1.4)      1.0                                                    (0.8--1.3)   1.0                                                    (0.8--1.3)
   Richer                   1.1                                                     (0.8--1.3)                    1.1                                                     (0.8--1.4)       0.9                                                      (0.7--1.3)                                                                         1.1                                                      (0.8--1.6)      1.21                                                   (1.0--1.5)   1.1                                                    (0.8--1.4)
   Richest                  1.4[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (1.1--1.9)                    1.2                                                     (0.9--1.7)       1.31                                                     (0.9--1.7)                                                                         1.8[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}       (1.2--2.8)      1.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (1.3--2.0)   1.1                                                    (0.8--1.5)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Place of residence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
   Urban                    Ref                                                                                   Not included in the final model                         Ref (0.7--1.1)                                                            Not included in the final model 0.8[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}   Ref                                                                      Ref                                                                                                                        
   Rural                    0.9                                                     (0.7--1.1)                    0.9                                                                                                                                                                                                                  (0.7--1.0)                                                               0.9                                                    (0.8--1.1)                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Province                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   Province 1               Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Province 2               0.7[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}        (0.5--1.0)                    0.8                                                     (0.6--1.2)       0.8                                                      (0.6--1.2)                                                                         0.9                                                      (0.6--1.5)      1.0                                                    (0.7--1.3)   1.2                                                    (0.9--1.8)
   Province 3               1.31                                                    (0.9--1.8)                    1.1                                                     (0.7--1.6)       1.0                                                      (0.7--1.4)                                                                         0.8                                                      (0.5--1.2)      1.7[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}     (1.2--2.2)   1.4                                                    (1.0--1.9)
   Province 4               1.8[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (1.3--2.5)                    1.5[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}        (1.0--2.2)       1.41                                                     (1.0--2.1)                                                                         1.4                                                      (0.9--2.2)      1.8[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (1.3--2.4)   1.5[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.1--2.1)
   Province 5               1.2                                                     (0.9--1.7)                    1.3                                                     (0.9--1.9)       1.3                                                      (0.9--1.8)                                                                         1.5                                                      (1.0--2.2)      1.5[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.1--2.0)   1.6[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}     (1.2--2.2)
   Province 6               0.7[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}        (0.5--0.9)                    0.8                                                     (0.5--1.2)       0.6[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}         (0.4--1.0)                                                                         0.8                                                      (0.5--1.4)      1.31                                                   (0.9--1.7)   1.3                                                    (0.9--1.9)
   Province 7               0.6[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}      (0.4--0.8)                    0.7                                                     (0.5--1.0)       0.71                                                     (0.5--1.1)                                                                         0.8                                                      (0.5--1.2)      0.9                                                    (0.6--1.2)   1.1                                                    (0.8--1.5)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Ecological region                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
   Mountains                Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Hills                    1.8[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}      (1.2--2.7)                    1.4                                                     (0.9--2.2)       1.51                                                     (0.9--2.3)                                                                         1.2                                                      (0.7--2.1)      1.4[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}       (1.0--2.0)   1.2                                                    (0.8--1.7)
   The Terai                1.2                                                     (0.8--1.8)                    1.1                                                     (0.7--1.7)       1.3                                                      (0.8--2.1)                                                                         1.1                                                      (0.6--2.0)      1.0                                                    (0.7--1.5)   0.9                                                    (0.6--1.4)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Body mass index                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
   Normal weight            Ref                                                                                   Ref                                                                      Ref                                                                                                                                         Ref                                                                      Ref                                                                 Ref                                                    
   Underweight              0.8[\*](#tfn4-ophrp-10-327){ref-type="table-fn"}        (0.6--1.0)                    0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (0.5--0.8)       1.5[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}       (1.2--2.0)                                                                         0.9                                                      (0.7--1.2)      0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (0.4--0.7)   0.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (0.5--0.8)
   Overweight/obese         2.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (1.9--2.6)                    2.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}    (1.9--2.6)       1.5[\*\*](#tfn5-ophrp-10-327){ref-type="table-fn"}       (1.2--1.8)                                                                         1.6[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}     (1.2--2.1)      2.5[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (2.2--2.9)   2.2[\*\*\*](#tfn6-ophrp-10-327){ref-type="table-fn"}   (1.9--2.6)

*p* \< 0.2,

*p* \< 0.05,

*p* \< 0.01,

*p* \< 0.001.

Variable with *p* \< 0.2 from unadjusted model were included into multivariate analysis STROBE 2007 (v4) Statement-Checklist of items that should be included in reports of cross-sectional studies.

ANC = antenatal care; AOR = adjusted odds ratio; CI = confidence interval; COR = crude odds ratio; ACC/AHA = American College of Cardiology/American Heart Association; SDH = systolic diastolic hypertension; ISH = isolated systolic hypertension; IDH = isolated diastolic hypertension.
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